◎ Control Lab
Data: 8.23.26 · SPY since seed: +20.8% · Goal N=150
Verdict
UNDERPERFORMING
p=0.002 · 95% CI: [-25.60, -5.49]
Need N≥150 treatment obs for p<0.05 significance. Currently 11/150 (7%)
Returns vs SPY — Gate-Filtered Random is the primary gate-effectiveness measurement
+60.3pp
Gate-Filtered (N=8)
+3.5pp
Random (N=488)
-0.5pp
FORMAL Recs (N=11)
GATE vs RANDOM  ·  REC-PROCESS GAP
Gate-Filtered vs Random: +56.4pp  ·  FORMAL Recs vs Gate-Filtered: -72.0pp
Both descriptive surface stats — not confirmatory hypothesis tests.
WIN RATE & AVG RETURN — DIRECTIONAL ONLY
Win%: Recs 7.0% vs Rnd 33.0%  ·  edge -26.0pp
AvgRet: Recs +2.5% vs Rnd +24.5% (-21.9pp)
⚠ Control from seed date, recs from rec date — windows not aligned
Return by Gate Score — does scoring higher = better returns?
Score tier Excess vs SPY N
6/6 (all gate) 0
4–5/6 +60.33pp 8
2–3/6 +12.68pp 35
0–1/6 +2.22pp 451
Direction Signals — locked vs control, tap header to sort
Metric Locked Control ✓✗ Streak Cohen d Sep
RSI higher higher 0✓ +0.579 22.18pp
rsi higher higher 1✓ +0.579 22.18pp
Dividend % lower lower 0✓ -0.557 12.41pp
Watson1 higher ? +0.339 12.81pp
EPS-ROA PE Score higher higher 51✓ +0.277 11.61pp
RSI-Net EBITDA Signal higher lower 0✗ +0.259 7.73pp
EPS next 5Y higher higher 1✓ +0.243 15.46pp
P/C Multiple lower lower 0✓ -0.218 29.04pp
P/C Multiple lower lower 1✓ -0.218 29.04pp
EV/EBITDA lower higher 0✗ +0.217 26.42pp
Alerts
⚠ 2 direction disagreement(s)
RSI-Net EBITDA Signal — locked higher · control lower
EV/EBITDA — locked lower · control higher
★ New signal candidates: Quality Value Score, Quality Value Score (Test Version), FCF Yiel : D/E, P/S v P/C Multiple, Profit Efficiency Value
✓ 4 control tickers scoring 4+/5 + outperforming: PTGX, CDNA, ACCL, PTRN
Top Combo Validation
No combo data
All Recommendations — tap header to sort
Ticker Date Rules Return Status
XBP 3/28/2026 4/6 0 Recommended
DLO 3/28/2026 6/6 0 Recommended
ABTC 3/28/2026 4/6 0 Recommended
PAAS 3/24/2026 5/6 Recommended
EVCM 3/24/2026 5/6 Recommended
NTST 3/24/2026 5/6 Recommended
ABBV 3/24/2026 5/6 Recommended
ITRN 3/24/2026 5/6 -2.07% Recommended+Bought
QNST 3/24/2026 5/6 Recommended
BWMX 3/24/2026 5/6 Recommended
TAK 3/24/2026 5/6 Recommended
HALO 3/24/2026 4/6 8.30% Recommended+Bought+Sold
CART 3/24/2026 4/6 -6.40% Recommended+Bought+Sold
ARM 2026-08-23 4/5 0.0000 Recommended
CAI 2026-08-23 4/5 0.0000 Recommended
FORM 2026-08-23 4/5 0.0000 Recommended
PTRN 2026-08-23 4/5 0.0000 Recommended
ANIK 2026-08-23 4/5 0.0000 Recommended
BLFS 2026-08-23 4/5 0.0000 Recommended
FSLY 2026-08-23 4/5 0.0000 Recommended
HNGE 2026-08-23 4/5 0.0000 Recommended
OMDA 2026-08-23 4/5 0.0000 Recommended
PTGX 2026-08-23 5/5 0.0000 Recommended
RDVT 2026-08-23 4/5 0.0000 Recommended
SMWB 2026-08-23 4/5 0.0000 Recommended
ACAD 2026-08-23 4/5 0.0000 Recommended
CPNG 2026-07-05 4/5 Recommended
TTWO 2026-07-05 4/5 Recommended
ACCL 2026-07-05 4/5 Recommended
QXO 2026-06-21 4/5 0.1126 Recommended
RSI 2026-06-14 4/5 0.0000 Recommended+Bought
ALGM 2026-06-07 4/5 0.0000 Recommended+Bought
ATRC 2026-06-07 4/5 0.0000 Recommended
MRCY 2026-06-07 4/5 0.0000 Recommended
U 2026-06-07 4/5 0.0000 Recommended
BLZE 2026-06-07 4/5 0.0000 Recommended
COMP 2026-06-07 4/5 0.0000 Recommended
RGR 2026-06-07 4/5 0.0000 Recommended
WYY 2026-06-07 4/5 0.0000 Recommended
CDNA 2026-06-07 4/5 0.0000 Recommended
MMI 2026-06-07 4/5 0.0000 Recommended
HY 2026-06-07 4/5 0.0000 Recommended
ASND 2026-06-07 4/5 0.0000 Recommended
AGYS 2026-06-05 4/5 0.0000 Recommended
GHM 2026-05-11 4/5 #DIV/0! Recommended+Bought+Sold
VECO 2026-05-10 4/5 0.0000 Recommended+Bought
WELL 2026-05-10 4/5 0.0000 Recommended+Bought
ARGX 2026-05-05 5/5 -3.5656 Recommended+Bought
SLNO 2026-05-02 4/5 0.0000 Recommended
GWRE 2026-04-30 4/5 6.7534 Recommended
RDDT 2026-04-29 5/5 #DIV/0! Recommended+Bought
SHOP 2026-04-29 5/5 #DIV/0! Recommended+Bought+Sold
ECO 2026-04-04 4/5 0.0000 Recommended
GRND 2026-04-01 4/5 0.3347 Recommended
ORLA 2026-04-01 4/5 1.9749 Recommended
SRAD 2026-04-01 4/5 1.7438 Recommended
EGAN 2026-03-31 5/5 -0.6337 Recommended
AU 2026-03-31 4/5 4.5399 Recommended
LII 2026-03-31 4/5 1.1850 Recommended